Treating human peripheral and tumor-infiltrating CD8 T cells with metformin in vitro increased the frequency of central memory and memory stem subtypes with increased expression of the proliferation marker and elevated resistance to apoptosis. This evidence concerns the gene CD8A and neoplasm.